{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T14:28:29Z","timestamp":1782311309761,"version":"3.54.5"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"FONDAZIONE CARIVERONA","award":["GR-2011-02350438"],"award-info":[{"award-number":["GR-2011-02350438"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1016\/j.ejphar.2019.172494","type":"journal-article","created":{"date-parts":[[2019,6,22]],"date-time":"2019-06-22T10:16:07Z","timestamp":1561198567000},"page":"172494","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Comparative transcriptome analysis of peripheral blood mononuclear cells in renal transplant recipients in everolimus- and tacrolimus-based immunosuppressive therapy"],"prefix":"10.1016","volume":"859","author":[{"given":"Simona","family":"Granata","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gloria","family":"Santoro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenzo","family":"Signorini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Malerba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Patuzzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Gambaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Stallone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianluigi","family":"Zaza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.ejphar.2019.172494_bib1","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1172\/JCI90962","article-title":"The role of the complement system in cancer","volume":"127","author":"Afshar-Kharghan","year":"2017","journal-title":"J. Clin. Investig."},{"issue":"3","key":"10.1016\/j.ejphar.2019.172494_bib2","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/labinvest.3780038","article-title":"A possible role of CD46 for the protection in vivo of human renal tumor cells from complement-mediated damage","volume":"80","author":"Blok","year":"2000","journal-title":"Lab. Investig."},{"issue":"11","key":"10.1016\/j.ejphar.2019.172494_bib3","doi-asserted-by":"crossref","first-page":"2520","DOI":"10.1111\/j.1600-6143.2009.02799.x","article-title":"Antibody-mediated microcirculation injury is the major cause of late kidney transplant failure","volume":"9","author":"Einecke","year":"2009","journal-title":"Am. J. Transplant."},{"issue":"6","key":"10.1016\/j.ejphar.2019.172494_bib4","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1172\/JCI41789","article-title":"A molecular classifier for predicting future graft loss in late kidney transplant biopsies","volume":"120","author":"Einecke","year":"2010","journal-title":"J. Clin. Investig."},{"issue":"25","key":"10.1016\/j.ejphar.2019.172494_bib5","doi-asserted-by":"crossref","first-page":"2562","DOI":"10.1056\/NEJMoa067411","article-title":"Reduced exposure to calcineurin inhibitors in renal transplantation","volume":"357","author":"Ekberg","year":"2007","journal-title":"N. Engl. J. Med."},{"issue":"17","key":"10.1016\/j.ejphar.2019.172494_bib6","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1001\/jama.2011.1592","article-title":"Spectrum of cancer risk among US solid organ transplant recipients","volume":"306","author":"Engels","year":"2011","journal-title":"J. Am. Med. Assoc."},{"key":"10.1016\/j.ejphar.2019.172494_bib7","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1186\/s12885-015-1734-7","article-title":"The human complement inhibitor Sushi Domain-Containing Protein 4 (SUSD4) expression in tumor cells and infiltrating T cells is associated with better prognosis of breast cancer patients","volume":"15","author":"Englund","year":"2015","journal-title":"BMC Canc."},{"key":"10.1016\/j.ejphar.2019.172494_bib8","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/S0306-4522(98)00108-0","article-title":"Complement C5a anaphylatoxin fragment causes apoptosis in TGW neuroblastoma cells","volume":"86","author":"Farkas","year":"1998","journal-title":"Neuroscience"},{"issue":"10","key":"10.1016\/j.ejphar.2019.172494_bib9","doi-asserted-by":"crossref","first-page":"3390","DOI":"10.1016\/j.transproceed.2014.08.044","article-title":"Everolimus associated with low-dose calcineurin inhibitors, an option in kidney transplant recipients of very old donors","volume":"46","author":"Furian","year":"2014","journal-title":"Transplant. Proc."},{"issue":"5","key":"10.1016\/j.ejphar.2019.172494_bib10","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1681\/ASN.2009101043","article-title":"Long-term cancer risk of immunosuppressive regimens after kidney transplantation","volume":"21","author":"Gallagher","year":"2010","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.ejphar.2019.172494_bib11","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1186\/1471-2407-9-384","article-title":"Cooperation of decay-accelerating factor and membrane cofactor protein in regulating survival of human cervical cancer cells","volume":"9","author":"Gao","year":"2009","journal-title":"BMC Canc."},{"issue":"Suppl. 2","key":"10.1016\/j.ejphar.2019.172494_bib12","doi-asserted-by":"crossref","first-page":"S29","DOI":"10.2215\/CJN.02690707","article-title":"Cardiovascular disease in transplant recipients: current and future treatment strategies","volume":"3","author":"Gill","year":"2008","journal-title":"Clin. J. Am. Soc. Nephrol."},{"issue":"9","key":"10.1016\/j.ejphar.2019.172494_bib13","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1084\/jem.20061022","article-title":"Complement activation induces dysregulation of angiogenic factors and causes fetal rejection and growth restriction","volume":"203","author":"Girardi","year":"2006","journal-title":"J. Exp. Med."},{"issue":"5","key":"10.1016\/j.ejphar.2019.172494_bib14","doi-asserted-by":"crossref","first-page":"E735","DOI":"10.3390\/ijms17050735","article-title":"Sirolimus and everolimus pathway: reviewing candidate genes influencing their intracellular effects","volume":"17","author":"Granata","year":"2016","journal-title":"Int. J. Mol. Sci."},{"issue":"Suppl. 4","key":"10.1016\/j.ejphar.2019.172494_bib15","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/ajt.12093","article-title":"Introduction: infections in solid organ transplantation","volume":"13","author":"Green","year":"2013","journal-title":"Am. J. Transplant."},{"issue":"2","key":"10.1016\/j.ejphar.2019.172494_bib16","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1038\/ki.2013.300","article-title":"Antibody-mediated rejection, T cell-mediated rejection, and the injury-repair response: new insights from the Genome Canada studies of kidney transplant biopsies","volume":"85","author":"Halloran","year":"2014","journal-title":"Kidney Int."},{"key":"10.1016\/j.ejphar.2019.172494_bib17","doi-asserted-by":"crossref","first-page":"2355","DOI":"10.1096\/fj.12-222042","article-title":"Sushi domain-containing protein 4 (SUSD4) inhibits complement by disrupting the formation of the classical C3 convertase","volume":"27","author":"Holmquist","year":"2013","journal-title":"FASEB J."},{"key":"10.1016\/j.ejphar.2019.172494_bib18","doi-asserted-by":"crossref","first-page":"797","DOI":"10.4049\/jimmunol.173.2.797","article-title":"Mechanism by which orally administered beta-1,3-glucans enhance the tumoricidal activity of antitumor monoclonal antibodies in murine tumor models","volume":"173","author":"Hong","year":"2004","journal-title":"J. Immunol."},{"issue":"22","key":"10.1016\/j.ejphar.2019.172494_bib19","doi-asserted-by":"crossref","first-page":"7831","DOI":"10.1128\/MCB.22.22.7831-7841.2002","article-title":"Activation of Akt\/protein kinase B overcomes a G(2)\/m cell cycle checkpoint induced by DNA damage","volume":"22","author":"Kandel","year":"2002","journal-title":"Mol. Cell. Biol."},{"issue":"16","key":"10.1016\/j.ejphar.2019.172494_bib20","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1097\/WNR.0b013e32833f19f2","article-title":"EMR-3: a potential mediator of invasive phenotypic variation in glioblastoma and novel therapeutic target","volume":"21","author":"Kane","year":"2010","journal-title":"Neuroreport"},{"issue":"2 Suppl. l","key":"10.1016\/j.ejphar.2019.172494_bib21","doi-asserted-by":"crossref","first-page":"25S","DOI":"10.1016\/j.transproceed.2004.01.018","article-title":"Pharmacology of calcineurin antagonists","volume":"36","author":"Kapturczak","year":"2004","journal-title":"Transplant. Proc."},{"issue":"10","key":"10.1016\/j.ejphar.2019.172494_bib22","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1007\/s00262-005-0672-7","article-title":"Expression of complement protein C5a in a murine mammary cancer model: tumor regression by interference with the cell cycle","volume":"54","author":"Kim","year":"2005","journal-title":"Cancer Immunol. Immunother."},{"issue":"14","key":"10.1016\/j.ejphar.2019.172494_bib23","doi-asserted-by":"crossref","first-page":"265","DOI":"10.21037\/atm.2016.06.26","article-title":"The dual role of complement in cancer and its implication in anti-tumor therapy","volume":"4","author":"Kourtzelis","year":"2016","journal-title":"Ann. Transl. Med."},{"issue":"5","key":"10.1016\/j.ejphar.2019.172494_bib24","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1128\/MCB.22.5.1513-1525.2002","article-title":"Identification of Akt association and oligomerization domains of the Akt kinase coactivator TCL1","volume":"22","author":"Kunstle","year":"2002","journal-title":"Mol. Cell. Biol."},{"issue":"2","key":"10.1016\/j.ejphar.2019.172494_bib25","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/S1097-2765(00)00039-3","article-title":"The protooncogene TCL1 is an Akt kinase coactivator","volume":"6","author":"Laine","year":"2000","journal-title":"Mol. Cell"},{"issue":"22","key":"10.1016\/j.ejphar.2019.172494_bib26","doi-asserted-by":"crossref","first-page":"4395","DOI":"10.1182\/blood-2010-01-261503","article-title":"Complement-mediated inhibition of neovascularization reveals a point of convergence between innate immunity and angiogenesis","volume":"116","author":"Langer","year":"2010","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.ejphar.2019.172494_bib27","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/S0046-8177(96)90346-9","article-title":"Tumor-specific deposition of immunoglobulin G and complement in papillary thyroid carcinoma","volume":"27","author":"Lucas","year":"1996","journal-title":"Hum. Pathol."},{"issue":"3","key":"10.1016\/j.ejphar.2019.172494_bib28","doi-asserted-by":"crossref","first-page":"168","DOI":"10.5500\/wjt.v4.i3.168","article-title":"Complement cascade and kidney transplantation: the rediscovery of an ancient enemy","volume":"4","author":"Mella","year":"2014","journal-title":"World J. Transplant."},{"issue":"12","key":"10.1016\/j.ejphar.2019.172494_bib29","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1038\/ki.2011.245","article-title":"Progressive histological damage in renal allografts is associated with expression of innate and adaptive immunity genes","volume":"80","author":"Naesens","year":"2011","journal-title":"Kidney Int."},{"issue":"3","key":"10.1016\/j.ejphar.2019.172494_bib30","doi-asserted-by":"crossref","first-page":"230","DOI":"10.4161\/cbt.23294","article-title":"Antiproliferative effect of a novel mTOR inhibitor temsirolimus contributes to the prolonged survival of orthotopic esophageal cancer-bearing mice","volume":"14","author":"Nishikawa","year":"2013","journal-title":"Cancer Biol. Ther."},{"issue":"10","key":"10.1016\/j.ejphar.2019.172494_bib31","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1096\/fj.06-7684com","article-title":"Proto-oncogene TCL1: more than just a coactivator for Akt","volume":"21","author":"Noguchi","year":"2007","journal-title":"FASEB J."},{"issue":"7","key":"10.1016\/j.ejphar.2019.172494_bib32","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1681\/ASN.2018010009","article-title":"Everolimus with reduced calcineurin inhibitor exposure in renal transplantation","volume":"29","author":"Pascual","year":"2018","journal-title":"J. Am. Soc. Nephrol."},{"issue":"7","key":"10.1016\/j.ejphar.2019.172494_bib33","doi-asserted-by":"crossref","first-page":"3028","DOI":"10.1073\/pnas.97.7.3028","article-title":"Tcl1 enhances Akt kinase activity and mediates its nuclear translocation","volume":"97","author":"Pekarsky","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"134","key":"10.1016\/j.ejphar.2019.172494_bib34","doi-asserted-by":"crossref","first-page":"ra60","DOI":"10.1126\/scisignal.2001104","article-title":"The PI3K isoforms p110alpha and p110delta are essential for pre-B cell receptor signaling and B cell development","volume":"3","author":"Ramadani","year":"2010","journal-title":"Sci. Signal."},{"issue":"1","key":"10.1016\/j.ejphar.2019.172494_bib35","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1002\/path.4553","article-title":"A type I interferon signature characterizes chronic antibody-mediated rejection in kidney transplantation","volume":"237","author":"Rascio","year":"2015","journal-title":"J. Pathol."},{"issue":"1","key":"10.1016\/j.ejphar.2019.172494_bib36","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines6010029","article-title":"Role of akt isoforms controlling cancer stem cell survival, phenotype and self-renewal","volume":"6","author":"Rivas","year":"2018","journal-title":"Biomedicines"},{"issue":"6","key":"10.1016\/j.ejphar.2019.172494_bib37","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/gm253","article-title":"Biomarkers in solid organ transplantation: establishing personalized transplantation medicine","volume":"3","author":"Roedder","year":"2011","journal-title":"Genome Med."},{"issue":"2","key":"10.1016\/j.ejphar.2019.172494_bib38","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1111\/j.1600-6143.2011.03840.x","article-title":"Understanding the causes of kidney transplant failure: the dominant role of antibody-mediated rejection and nonadherence","volume":"12","author":"Sellar\u00e9s","year":"2012","journal-title":"Am. J. Transplant."},{"issue":"22","key":"10.1016\/j.ejphar.2019.172494_bib39","doi-asserted-by":"crossref","first-page":"18863","DOI":"10.1074\/jbc.M101147200","article-title":"Human epidermal growth factor (EGF) module-containing mucin-like hormone receptor 3 is a new member of the EGF-TM7 family that recognizes a ligand on human macrophages and activated neutrophils","volume":"276","author":"Stacey","year":"2001","journal-title":"J. Biol. Chem."},{"issue":"13","key":"10.1016\/j.ejphar.2019.172494_bib40","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1056\/NEJMoa042831","article-title":"Sirolimus for Kaposi's sarcoma in renal-transplant recipients","volume":"352","author":"Stallone","year":"2005","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.ejphar.2019.172494_bib41","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.trim.2008.01.007","article-title":"Microarray analysis of MicroRNA expression in acute rejection after renal transplantation","volume":"19","author":"Sui","year":"2008","journal-title":"Transpl. Immunol."},{"issue":"8","key":"10.1016\/j.ejphar.2019.172494_bib42","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1038\/nrc1672","article-title":"The TCL1 family of oncoproteins: co-activators of transformation","volume":"5","author":"Teitell","year":"2005","journal-title":"Nat. Rev. Canc."},{"key":"10.1016\/j.ejphar.2019.172494_bib43","series-title":"USRDS Annual Data Report: Epidemiology of Kidney Disease in the United States","year":"2017"},{"issue":"7","key":"10.1016\/j.ejphar.2019.172494_bib44","doi-asserted-by":"crossref","first-page":"2836","DOI":"10.1182\/blood-2004-07-2878","article-title":"CD97, an adhesion receptor on inflammatory cells, stimulates angiogenesis through binding integrin counterreceptors on endothelial cells","volume":"105","author":"Wang","year":"2005","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.ejphar.2019.172494_bib45","doi-asserted-by":"crossref","first-page":"5256","DOI":"10.1074\/jbc.M008552200","article-title":"Akt activation protects hippocampal neurons from apoptosis by inhibiting transcriptional activity of p53","volume":"276","author":"Yamaguchi","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2019.172494_bib46","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.tibs.2008.07.005","article-title":"Adhesion-GPCRs: emerging roles for novel receptors","volume":"33","author":"Yona","year":"2008","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.ejphar.2019.172494_bib47","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/403280","article-title":"Systemic and nonrenal adverse effects occurring in renal transplant patients treated with mTOR inhibitors","volume":"2013","author":"Zaza","year":"2013","journal-title":"Clin. Dev. Immunol."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299919304467?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299919304467?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T04:06:13Z","timestamp":1762142773000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299919304467"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":47,"alternative-id":["S0014299919304467"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2019.172494","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparative transcriptome analysis of peripheral blood mononuclear cells in renal transplant recipients in everolimus- and tacrolimus-based immunosuppressive therapy","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2019.172494","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"172494"}}